Inhibition of spinal bone formation in AS: 10 years after comparing adalimumab to OASIS
Abstract A decade has passed since the publication on the comparison of the effect of adalimumab with data from a historic cohort on the progression of structural damage in the spine of patients with ankylosing spondylitis (AS). No effect could be observed, and currently, there is still no definite...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Jezik: | English |
| Izdano: |
BMC
2019-11-01
|
| Serija: | Arthritis Research & Therapy |
| Teme: | |
| Online dostop: | http://link.springer.com/article/10.1186/s13075-019-2045-1 |